ergotamine

(redirected from Ergotamines)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Ergotamines: Ergotamine tartrate, Triptans

er·got·a·mine

 (ûr-gŏt′ə-mēn′, -mĭn)
n.
A crystalline alkaloid, C33H35N5O5, derived from ergot that induces vasoconstriction and is used especially in treating migraine.

ergotamine

(ɜːˈɡɒtəˌmiːn)
n
(Medicine) med an alkaloid from ergot that is used to treat migraines

er•got•a•mine

(ɜrˈgɒt əˌmin, -mɪn)

n.
a crystalline, water-soluble polypeptide, C33H35N5O5, obtained from ergot, used to stimulate uterine contractions during labor and in the treatment of migraine.
[1920–25]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.ergotamine - an alkaloid derived from ergot that is less toxic than ergot; causes constriction of blood vessels and is used to treat migraine
alkaloid - natural bases containing nitrogen found in plants
Translations
ergotamiini

er·got·a·mine

n. ergotamina, alcaloide usado en el tratamiento de migraña.

ergotamine

n ergotamina
Mentioned in ?
References in periodicals archive ?
There are some downsides in terms of side effects--most notably the akathisia with droperidol--but they are quite effective and represent a very nice alternative to using opioid preparations or to using a more vasoactive medication, such as the triptans or the ergotamines, in patients with acute migraines," he said in a review of studies on several dopamine antagonists.
The ergotamines and the triptans, unlike NSAIDs and opiates, are considered to be migraine-specific medications.
In addition to the triptans, aspirin, ergotamines, and isometheptene should be avoided.
Importantly, because there was no evidence of drug-related cardiovascular effects or chest symptoms in the previous six clinical studies, CoLucid expects that the pivotal Phase 3 studies will confirm that lasmiditan's side effect profile is highly differentiated from triptans and ergotamines.
Patients who cannot take dihydroergotamine or dopamine antagonists or who have recently taken ergotamines or triptans without relief may receive greatest benefit from IV valproate.
Importantly, because there was no evidence of drug-related cardiovascular effects or chest symptoms in the previous five clinical studies, CoLucid expects the pivotal Phase 3 studies to confirm that lasmiditan's side effect profile is highly differentiated from triptans and ergotamines.